Sign in
Download Opera News App



Health Living


Disease prevention and treatment

Uproar As The High Price Of The New HIV Drug Is Revealed By The Government.

A new HIV drug that will cost Ksh5.1 million for the first two shots has been approved by the United States Food and Drug Administration (FDA).

The drug, which will be administered in form of two shots, will also require patients to partake yearly booster shots costing Ksh4.7 million each.

According to the FDA, the drug known as Sunlenca will be only administered to HIV-positive adults.

The drug functions by obstructing the capsid protein coat of the HIV-1 virus, interfering with the viral life cycle.

In a clinical trial, 83 percent of patients taking Sunlenca with a combination of other drugs achieved an undetectable viral load. This accounted for approval of the drug by United States Food and Drug Administration.Though the drug is so expensive.

The medication which is strictly for adults patients living with HIV-1, whose HIV infection cannot be treated with other available treatments due to resistance, intolerance or safety considerations.

Content created and supplied by: Managu (via Opera News )

FDA HIV HIV-positive Sunlenca United States Food and Drug


Load app to read more comments